Results for tag: "Pet Vaccine"

The pet vaccine market is a segment within the broader animal healthcare or veterinary industry, focusing on the development, manufacturing, and distribution of vaccines for companion animals such as dogs, cats, and horses. This market addresses the prevention of various infectious diseases that can affect pets and, in some cases, can be transmitted to humans, such as rabies and leptospirosis. Veterinary vaccines are considered an essential component of preventive veterinary medicine, helping to maintain animal health, enhance their quality of life, and reduce the potential for outbreaks of diseases in both pet populations and the wider community. Pet vaccines are often categorized into core and non-core vaccines. Core vaccines are those recommended for all animals of a particular species because of the widespread risk of the disease, its severity, or transmissibility to humans. Non-core vaccines are administered based on a pet's exposure risk, which can be influenced by geographic location and lifestyle. The pet vaccine market operates in conjunction with veterinary clinics, hospitals, and research organizations to ensure advancements in immunization technology and the adoption of vaccination protocols. Some companies that are key players in the pet vaccine market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, and Virbac. These companies are involved in the research, production, and commercialization of a range of vaccines for pets, offering both core and non-core vaccines to the market. Additionally, these firms engage in educational programs for veterinarians and pet owners to promote the awareness and benefits of pet Show Less Read more